Dr. Brad Isaacson recently joined The Geneva Foundation as a Principal Investigator. He has a Bachelor of Science Degree in (BS) Mechanical Engineering from Widener University, a Doctorate of Philosophy (PhD) in Bioengineering from the University of Utah, and a Master of Business Administration (MBA) and Master of Science in Finance (MSF) from Boston College. Dr. Isaacson is an Associate Professor in Physical Medicine & Rehabilitation (Uniformed Services University, USU) and Orthopedics (University of Utah), holds 8 United States patents, and has published 25+ peer-reviewed publications on military medicine. He has 10+ years of demonstrated experience in project management, operations, device development, and scientific study methodology.
Dr. Isaacson was previously employed by the Henry M. Jackson Foundation (HJF) as the Program Manager and Lead Scientist for the Center for Rehabilitation Sciences Research (CRSR), an organization headquartered at USU, which is dedicated to helping combat-injured service members with cognitive, neurological and orthopedic injuries. During his tenure with HJF between 2011-2018, Dr. Isaacson and the center Director, Dr. Paul Pasquina, grew CRSR from inception to over $75 million and 70 research studies.
As a Lead Scientist for CRSR/HJF, Dr. Isaacson advanced the standard of care for combat injured service members with heterotopic ossification (HO), which is ectopic bone formation that occurs following limb loss or major extremity injuries. Dr. Isaacson’s research has sought to understand the association between clinical and histological predictors of HO, and his work has been featured on the Department of the Army’s website, funded through numerous Department of Defense awards, and he and his colleagues have the only translatable model for understanding the etiology of this pathological condition. Dr. Isaacson’s research is critical for improved surgical planning and reduce HO recurrence in our service members.
In addition to his programmatic and scientific contributions, during the period of 2011-2013, Dr. Isaacson was a Lead Research & Development Engineer at Boston Scientific and he developed a device to remove cancerous masses in the upper gastrointestinal track.
In his new role at Geneva, Dr. Isaacson will provide operational support for the organization while continuing key scientific and programmatic leadership efforts for CRSR. Dr. Isaacson currently resides in Salt Lake City, Utah with his wife Megan, a retired Army Captain who served in Afghanistan in the Nurse Corp, and their 3 daughters: Lily, Hanna, and Claire.
“I am humbled to be working with such a wonderful organization that provides both personal and professional growth. Developing evidence-based military medicine has been my vision for the past decade and The Geneva Foundation is affording me opportunities to give back to those who truly need advanced rehabilitative care.” said Dr. Isaacson.